Verastem Oncology Launches HCP and Patient Reimagine Campaign to Increase Awareness of AVMAPKI® FAKZYNJA® CO-PACK for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer
Go back to Verastem Oncology Launches HCP and Patient Reimagine Campaign to Increase Awareness of AVMAPKI® FAKZYNJA® CO-PACK for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer| VERASTEM SHS (NASDAQ: VSTM) | Delayed: 4.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.21 | 52 Week High | $2.43 | |||
| Open | $4.21 | 52 Week Low | $1.05 | |||
| Day High | $4.21 | P/E | N/A | |||
| Day Low | $4.21 | EPS | $-1.79 | |||
| Volume | 2,085 | |||||
